AI English summary of an SEC filing — figures as filed
Biogen BIIBThe company said it was notified by Chief Financial Officer Michael McDonnell that he will retire effective February 28, 2025, and that Chief Accounting Officer Robin Kramer will become Chief Financial Officer upon his retirement. It said the notice came on October 28, 2024.
Key points
AI summaryThe company said it was notified by Chief Financial Officer Michael McDonnell that he will retire effective February 28, 2025, and that Chief Accounting Officer Robin Kramer will become Chief Financial Officer upon his retirement. It said the notice came on October 28, 2024.
The company said Kramer joined it in 2018 and has served as Senior Vice President and Chief Accounting Officer since December 2020. Before joining the company, she held senior finance roles at Hertz Global Holdings, Inc., Fisher Scientific International, Inc. and The Gillette Company.
Biogen said Kramer's base salary will be $750,000, and she is eligible for an annual bonus with a target of 80% of base salary. It also disclosed that her target long-term incentive grant value for 2025 will be $3,750,000.
The company said Ms. Kramer will receive a lump sum severance payment equal to a minimum of 12 months of her base salary plus target bonus if she is terminated without cause, with an additional 2 months for each 1 full year of service, up to a maximum of 21 months. If she is terminated without cause or experiences an involuntary employment action within 2 years after a corporate transaction or change in control, she will receive a lump sum payment equal to 2 times her base salary plus target bonus.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
CFO transition: McDonnell to retire, Robin Kramer to succeed
The company said it was notified by Chief Financial Officer Michael McDonnell that he will retire effective February 28, 2025, and that Chief Accounting Officer Robin Kramer will become Chief Financial Officer upon his retirement. It said the notice came on October 28, 2024.
Source · Based on the filing body and exhibits
Kramer's background and current board roles
The company said Kramer joined it in 2018 and has served as Senior Vice President and Chief Accounting Officer since December 2020. Before joining the company, she held senior finance roles at Hertz Global Holdings, Inc., Fisher Scientific International, Inc. and The Gillette Company.
Source · Based on the filing body and exhibits
Kramer's base salary, target bonus and 2025 LTI
Biogen said Kramer's base salary will be $750,000, and she is eligible for an annual bonus with a target of 80% of base salary. It also disclosed that her target long-term incentive grant value for 2025 will be $3,750,000.
Source · Based on the filing body and exhibits
Severance terms for Executive Vice Presidents under the plan
The company said Ms. Kramer will receive a lump sum severance payment equal to a minimum of 12 months of her base salary plus target bonus if she is terminated without cause, with an additional 2 months for each 1 full year of service, up to a maximum of 21 months. If she is terminated without cause or experiences an involuntary employment action within 2 years after a corporate transaction or change in control, she will receive a lump sum payment equal to 2 times her base salary plus target bonus.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…